SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-17-038432
Filing Date
2017-06-09
Accepted
2017-06-09 16:32:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 a17-15001_2425.htm 425 16557
2 GRAPHIC g150012bgi001.jpg GRAPHIC 4843
  Complete submission text file 0001104659-17-038432.txt   24967
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37558 | Film No.: 17903342
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 6108166640
Nabriva Therapeutics Plc (Filed by) CIK: 0001703287 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations